ClinicalTrials.Veeva

Menu

Vasoactive Peptides in Portal Pressure

B

Bayside Health

Status

Unknown

Conditions

Portal Hypertension

Treatments

Drug: Norfloxacin

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study is looking at the detection of vasoactive peptides in portal hypertension.

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • HVPG >= 12 mmHg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Central trial contact

William W Kemp, MBBS, FRACP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems